UK uses virtual reality for pharmaceutical manufacturing training

The United Kingdom has initiated the RESILIENCE project, a program designed to address the pharmaceutical industry's shortage of skilled workers by employing virtual reality (VR) for training. Launched in April 2024, the initiative allows early-career professionals and students to practice medicine manufacturing processes in a virtual environment.

RESILIENCE serves as the UK's Medicines Manufacturing Skills Centre of Excellence, focused on strengthening the life sciences industry, particularly pharmaceutical manufacturing and innovations like gene therapies. The project aims to cultivate new talent and fill an estimated 150,000 new roles within the UK over the next decade.

The program responds to evolving manufacturing needs, driven by new modalities such as biologic medicines and cell and gene therapies, which require different skills from traditional drug production. Instead of costly and environmentally impactful traditional training methods, VR simulations offer a practical and risk-free alternative.

VR training has demonstrated benefits in boosting new employees' confidence and competence. Early participants have reported feeling fully prepared for their roles from day one. University students have also found VR training more effective and beneficial than conventional teaching methods, leading to enhanced theoretical and practical skills.